Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist
PHASE2CompletedINTERVENTIONAL
Enrollment
85
Participants
Timeline
Start Date
June 30, 1995
Study Completion Date
June 30, 2002
Conditions
Acquired Immunodeficiency SyndromeHIV Infection
Interventions
DRUG
IL-2 plus Anti-TNF or Thalidomide
Trial Locations (1)
20892
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda
All Listed Sponsors
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00001475 - Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist | Biotech Hunter | Biotech Hunter